{"id":45180,"date":"2012-05-20T08:16:17","date_gmt":"2012-05-20T08:16:17","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/osiris-shares-climb-on-stem-cell-therapy-approval.php"},"modified":"2012-05-20T08:16:17","modified_gmt":"2012-05-20T08:16:17","slug":"osiris-shares-climb-on-stem-cell-therapy-approval","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/osiris-shares-climb-on-stem-cell-therapy-approval.php","title":{"rendered":"Osiris shares climb on stem-cell therapy approval"},"content":{"rendered":"<p>Shares of Osiris Therapeutics traded higher Friday, a day after Canadian regulators approved the company&#39;s first-of-a-kind stem cell therapy Prochymal, a treatment for a deadly side effect of bone marrow transplants.<\/p>\n<p>Read more:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/news.yahoo.com\/osiris-shares-climb-stem-cell-therapy-approval-145016213--finance.html;_ylt=A2KJjahOqLhPLBEA47f_wgt.\" title=\"Osiris shares climb on stem-cell therapy approval\">Osiris shares climb on stem-cell therapy approval<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Shares of Osiris Therapeutics traded higher Friday, a day after Canadian regulators approved the company&#39;s first-of-a-kind stem cell therapy Prochymal, a treatment for a deadly side effect of bone marrow transplants. <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/osiris-shares-climb-on-stem-cell-therapy-approval.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[25],"tags":[],"class_list":["post-45180","post","type-post","status-publish","format-standard","hentry","category-stem-cell-therapy"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/45180"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=45180"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/45180\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=45180"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=45180"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=45180"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}